Success Metrics

Active Trials
2(33%)

Phase Distribution

Ph phase_3
1
17%
Ph phase_1
1
17%
Ph not_applicable
1
17%
Ph phase_2
3
50%

Phase Distribution

1

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
3(50.0%)
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(6)

Detailed Status

Not yet recruiting4
Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 11 (16.7%)
Phase 23 (50.0%)
Phase 31 (16.7%)
N/A1 (16.7%)

Trials by Status

recruiting117%
not_yet_recruiting467%
active_not_recruiting117%

Recent Activity

2 active trials
Showing 5 of 6
not_yet_recruitingphase_2

Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial Cancer

NCT07820358
not_yet_recruitingphase_3

SEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years

NCT07845994
not_yet_recruitingphase_2

Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes Mellitus

NCT07797036
active_not_recruitingphase_2

Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss

NCT07446998
recruitingnot_applicable

OBESIAL: A Prospective Interventional Real-world Study of a Multidisciplinary Obesity Management Programme

NCT07779343
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07820358Phase 2

Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial Cancer

Not Yet Recruiting
NCT07845994Phase 3

SEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years

Not Yet Recruiting
NCT07797036Phase 2

Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes Mellitus

Not Yet Recruiting
NCT07446998Phase 2

Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss

Active Not Recruiting
NCT07779343Not Applicable

OBESIAL: A Prospective Interventional Real-world Study of a Multidisciplinary Obesity Management Programme

Recruiting
NCT07430059Phase 1

Safety, Tolerability and Pharmacokinetics of a Subcutaneous Semaglutide Implant

Not Yet Recruiting

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6